You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API epoprostenol sodium

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing epoprostenol sodium

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
GlaxoSmithKline LLC	FLOLAN	epoprostenol sodium	0173-0517	GLYCINE
GlaxoSmithKline LLC	FLOLAN	epoprostenol sodium	0173-0517	MANNITOL
GlaxoSmithKline LLC	FLOLAN	epoprostenol sodium	0173-0517	SODIUM CHLORIDE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing epoprostenol sodium

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985	GLYCINE
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985	MANNITOL
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985	SODIUM CHLORIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for epoprostenol sodium

Excipient focus: GLYCINE

epoprostenol sodium drug variants containing GLYCINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol sodium drug variants not containing GLYCINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

epoprostenol sodium drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol sodium drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

epoprostenol sodium drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol sodium drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

epoprostenol sodium drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol sodium drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.